Literature DB >> 27161458

Unruptured Epileptogenic Brain Arteriovenous Malformations.

Yong Sun1, Ren-Fu Tian, Ai-Min Li, Xi-Guang Liu, Jun Chen, Hui Shi.   

Abstract

AIM: To determine whether specific clinical and radiographic factors predispose arteriovenous malformations (AVMs) presenting with seizure and to predict the seizure risk for individual AVM patients.
MATERIAL AND METHODS: Clinical features and cerebral angiograms of consecutive 45 unruptured AVM patients who were diagnosed in our center in a 2-year period were reviewed. Patient data (analysis cohort) was used to determine risk factors for seizure and to construct epileptogenic AVM groups. These risk groups were tested with the second half of the patient data (test cohort).
RESULTS: Among 45 unruptured AVMs (47.9%), initial seizures occurred in 20 unruptured AVMs (44.4%). Two of these 20 patients had a bleed in 117 patient-years for an annual bleed rate of 1.7%. There was no significant difference in hemorrhagic risk between epileptogenic AVM and asymptomatic AVM (P=0.918). Multivariate analysis revealed 2 factors associated with seizure: frontal and temporal AVM locations (P < 0.001) and a compact AVM morphology (P=0.003).
CONCLUSION: Analysis of a group of unruptured AVMs demonstrated that epileptogenic AVMs have an annual hemorrhage risk similar to that of the asymptomatic AVMs. Frontal and temporal AVM locations and a compact AVM morphology were significantly associated with epileptogenic AVMs.

Entities:  

Mesh:

Year:  2016        PMID: 27161458     DOI: 10.5137/1019-5149.JTN.9190-13.1

Source DB:  PubMed          Journal:  Turk Neurosurg        ISSN: 1019-5149            Impact factor:   1.003


  1 in total

1.  Shortened cerebral circulation time correlates with seizures in brain arteriovenous malformation: a cross-sectional quantitative digital subtraction angiography study.

Authors:  Jing Kai Loo; Yong-Sin Hu; Te-Ming Lin; Chung-Jung Lin; Jiing-Feng Lirng; Hsiu-Mei Wu; Huai-Che Yang; Cheng-Chia Lee; Chao-Bao Luo; Wan-Yuo Guo
Journal:  Eur Radiol       Date:  2022-03-23       Impact factor: 7.034

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.